Latest Strategy News

A shareholder has lodged a formal application with the Takeovers Panel challenging FBR Limited’s recent share placements and governance practices, raising concerns over disclosure and shareholder engagement.

Top Shelf International Holdings has completed the sale of its Campbellfield production assets for $8 million, fully settling its ATO excise liability and advancing its financial restructuring.

Judo Capital Holdings Limited has announced a fully franked quarterly distribution of AUD 1.81682 per capital note, payable in August 2025. This payment reflects the company’s ongoing commitment to rewarding investors amid stable market conditions.

Raptis Group Limited has had its trading suspension lifted following the announcement of a placement and a pro-rata non-renounceable entitlement offer, signaling a fresh chapter for the company on the ASX.

Red Metal Limited’s latest leach test results from the Sybella rare earths discovery confirm promising low-cost processing potential using mild acid conditions, significantly reducing impurities and acid consumption. The findings pave the way for definitive column leach tests and expanded resource evaluation.

ADX Energy has formalised licence amendments and identified four drill-ready shallow gas prospects in Upper Austria, targeting Q4 2025 for initial drilling. The company is advancing farm-in discussions to capitalise on a low-risk, pipeline-proximate gas opportunity in a sought-after European market.

Adherium Limited has locked in $900,000 through convertible notes to fund the expansion of its Hailie® Smartinhaler® platform in the US, pending shareholder approval at the upcoming AGM.

HeraMED faces a setback as Broward Health discontinues its HeraCARE platform amid Medicaid funding cuts, prompting a strategic pivot with new leadership and partnerships to accelerate US growth.

Emu NL’s recent shareholder meeting saw all attempts to remove or elect new directors decisively rejected, reinforcing board stability as the company completes a planned capital raise.

Anatara Lifesciences has expanded its intellectual property footprint with a 20-year patent granted in Hong Kong for its GaRP gastrointestinal health product, following similar approvals in Europe and Australia. This milestone strengthens its commercial position in the lucrative global market for digestive health solutions.

Aurumin Limited has had its trading suspension lifted following the announcement of proposed material transactions involving non-gold mineral rights at its key projects.

Catalyst Metals has finalized the sale of its Henty gold mine to Kaiser Reef, securing $15 million in cash and a near 20% stake in Kaiser. This deal unlocks a strategic option to acquire half of the Maldon processing plant, bolstering Catalyst’s Victorian gold ambitions.